ArticleThe Journal of clinical investigation2025

First-generation and preclinical evaluation of an EphA5-targeted antibody-drug conjugate in solid tumors.

Fernanda I Staquicini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.